SCHEMBL9249307

SCHEMBL9249307

COC(=O)CCCC(=O)c1ccc2c(c1)nc(-c1ccc(C(=N)N)cc1)n2C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.47
HDAC8 Q9BY41 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47
HDAC3 O15379 2/20 0.46
HDAC2 Q92769 2/20 0.46
JAK2 O60674 4/20 0.42
JAK1 P23458 4/20 0.42
TYK2 P29597 4/20 0.42
JAK3 P52333 4/20 0.42
CHEK2 O96017 1/20 0.41
PTGER4 P35408 2/20 0.41
NAMPT P43490 1/20 0.41
F2 P00734 4/20 0.41
NQO2 P16083 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
TMPRSS15 P98073 1/20 0.40
F10 P00742 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9254928 0.98 HDAC1 (0.47) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9255124 0.89 HDAC1 (0.50) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251150 0.87 HDAC1 (0.50) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251773 0.87 HDAC1 (0.50) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL8863892 0.87 HDAC1 (0.49) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL9251702 0.85 HDAC1 (0.45) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL8863519 0.85 HDAC1 (0.52) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL9255053 0.84 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9256146 0.83 HDAC1 (0.45) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251154 0.83 NQO2 (0.48) HDAC1HDAC8HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5434150-A Anticoagulants, cardiovascular disorders DR. KARL THOMAE GMBH (DE) 1995-07-18 US disclosed
EP-0531883-A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-03-17 EP disclosed